ARISE: pAdsevonil in drug-ResIStant Epilepsy. A randomized, double-blind, placebo-controlled, dose finding study to evaluate the efficacy and safety of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug resistant epilepsy.

Project: Research

Project Details

StatusFinished
Effective start/end date11/12/1811/12/19